These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

59 related articles for article (PubMed ID: 34315958)

  • 21. Physical interventions to interrupt or reduce the spread of respiratory viruses.
    Jefferson T; Del Mar CB; Dooley L; Ferroni E; Al-Ansary LA; Bawazeer GA; van Driel ML; Jones MA; Thorning S; Beller EM; Clark J; Hoffmann TC; Glasziou PP; Conly JM
    Cochrane Database Syst Rev; 2020 Nov; 11(11):CD006207. PubMed ID: 33215698
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Determinants of Shielding Behavior During the COVID-19 Pandemic and Associations With Well-being Among National Health Service Patients: Longitudinal Observational Study.
    Bachtiger P; Adamson A; Maclean WA; Kelshiker MA; Quint JK; Peters NS
    JMIR Public Health Surveill; 2021 Sep; 7(9):e30460. PubMed ID: 34298499
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The impact of primary care supported shielding on the risk of mortality in people vulnerable to COVID-19: English sentinel network matched cohort study.
    Zarif A; Joy M; Sherlock J; Sheppard JP; Byford R; Akinyemi O; Bankhead CR; Deeks A; Ferreira F; Jones N; Liyanage H; McGagh D; Nicholson B; Oke J; Okusi C; Tripathy M; Williams J; Hobbs R; de Lusignan S
    J Infect; 2021 Aug; 83(2):228-236. PubMed ID: 34004222
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Relation of severe COVID-19 in Scotland to transmission-related factors and risk conditions eligible for shielding support: REACT-SCOT case-control study.
    McKeigue PM; McAllister DA; Caldwell D; Gribben C; Bishop J; McGurnaghan S; Armstrong M; Delvaux J; Colville S; Hutchinson S; Robertson C; Lone N; McMenamin J; Goldberg D; Colhoun HM
    BMC Med; 2021 Jun; 19(1):149. PubMed ID: 34158021
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Segmentation and shielding of the most vulnerable members of the population as elements of an exit strategy from COVID-19 lockdown.
    van Bunnik BAD; Morgan ALK; Bessell PR; Calder-Gerver G; Zhang F; Haynes S; Ashworth J; Zhao S; Cave RNR; Perry MR; Lepper HC; Lu L; Kellam P; Sheikh A; Medley GF; Woolhouse MEJ
    Philos Trans R Soc Lond B Biol Sci; 2021 Jul; 376(1829):20200275. PubMed ID: 34053266
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Challenges in determining causality: An ongoing critique of Bendavid et al's 'Assessing mandatory stay-at-home and business closure effects on the spread of COVID-19'.
    Besançon L; Meyerowitz-Katz G; Zanetti Chini E; Fuchs H; Flahault A
    Eur J Clin Invest; 2021 Aug; 51(8):e13599. PubMed ID: 33998694
    [No Abstract]   [Full Text] [Related]  

  • 28. Respectful disagreement: the covid-19 shielding list.
    Williams AN
    BMJ; 2021 Feb; 372():n382. PubMed ID: 33563605
    [No Abstract]   [Full Text] [Related]  

  • 29. The impact of COVID-19 on rheumatology patients in a large UK centre using an innovative data collection technique: prevalence and effect of social shielding.
    Cleaton N; Raizada S; Barkham N; Venkatachalam S; Sheeran TP; Adizie T; Sapkota H; Singh BM; Bateman J
    Rheumatol Int; 2021 Apr; 41(4):707-714. PubMed ID: 33559727
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Predictions of COVID-19 dynamics in the UK: Short-term forecasting and analysis of potential exit strategies.
    Keeling MJ; Hill EM; Gorsich EE; Penman B; Guyver-Fletcher G; Holmes A; Leng T; McKimm H; Tamborrino M; Dyson L; Tildesley MJ
    PLoS Comput Biol; 2021 Jan; 17(1):e1008619. PubMed ID: 33481773
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Is older age associated with COVID-19 mortality in the absence of other risk factors? General population cohort study of 470,034 participants.
    Ho FK; Petermann-Rocha F; Gray SR; Jani BD; Katikireddi SV; Niedzwiedz CL; Foster H; Hastie CE; Mackay DF; Gill JMR; O'Donnell C; Welsh P; Mair F; Sattar N; Celis-Morales CA; Pell JP
    PLoS One; 2020; 15(11):e0241824. PubMed ID: 33152008
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Factors associated with COVID-19-related death using OpenSAFELY.
    Williamson EJ; Walker AJ; Bhaskaran K; Bacon S; Bates C; Morton CE; Curtis HJ; Mehrkar A; Evans D; Inglesby P; Cockburn J; McDonald HI; MacKenna B; Tomlinson L; Douglas IJ; Rentsch CT; Mathur R; Wong AYS; Grieve R; Harrison D; Forbes H; Schultze A; Croker R; Parry J; Hester F; Harper S; Perera R; Evans SJW; Smeeth L; Goldacre B
    Nature; 2020 Aug; 584(7821):430-436. PubMed ID: 32640463
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Targeted adaptive isolation strategy for COVID-19 pandemic.
    Neufeld Z; Khataee H; Czirok A
    Infect Dis Model; 2020; 5():357-361. PubMed ID: 32587932
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Global, regional, and national estimates of the population at increased risk of severe COVID-19 due to underlying health conditions in 2020: a modelling study.
    Clark A; Jit M; Warren-Gash C; Guthrie B; Wang HHX; Mercer SW; Sanderson C; McKee M; Troeger C; Ong KL; Checchi F; Perel P; Joseph S; Gibbs HP; Banerjee A; Eggo RM;
    Lancet Glob Health; 2020 Aug; 8(8):e1003-e1017. PubMed ID: 32553130
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of non-pharmaceutical interventions on COVID-19 cases, deaths, and demand for hospital services in the UK: a modelling study.
    Davies NG; Kucharski AJ; Eggo RM; Gimma A; Edmunds WJ;
    Lancet Public Health; 2020 Jul; 5(7):e375-e385. PubMed ID: 32502389
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Estimating excess 1-year mortality associated with the COVID-19 pandemic according to underlying conditions and age: a population-based cohort study.
    Banerjee A; Pasea L; Harris S; Gonzalez-Izquierdo A; Torralbo A; Shallcross L; Noursadeghi M; Pillay D; Sebire N; Holmes C; Pagel C; Wong WK; Langenberg C; Williams B; Denaxas S; Hemingway H
    Lancet; 2020 May; 395(10238):1715-1725. PubMed ID: 32405103
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Modeling shield immunity to reduce COVID-19 epidemic spread.
    Weitz JS; Beckett SJ; Coenen AR; Demory D; Dominguez-Mirazo M; Dushoff J; Leung CY; Li G; Măgălie A; Park SW; Rodriguez-Gonzalez R; Shivam S; Zhao CY
    Nat Med; 2020 Jun; 26(6):849-854. PubMed ID: 32382154
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Patients with Cancer Appear More Vulnerable to SARS-CoV-2: A Multicenter Study during the COVID-19 Outbreak.
    Dai M; Liu D; Liu M; Zhou F; Li G; Chen Z; Zhang Z; You H; Wu M; Zheng Q; Xiong Y; Xiong H; Wang C; Chen C; Xiong F; Zhang Y; Peng Y; Ge S; Zhen B; Yu T; Wang L; Wang H; Liu Y; Chen Y; Mei J; Gao X; Li Z; Gan L; He C; Li Z; Shi Y; Qi Y; Yang J; Tenen DG; Chai L; Mucci LA; Santillana M; Cai H
    Cancer Discov; 2020 Jun; 10(6):783-791. PubMed ID: 32345594
    [TBL] [Abstract][Full Text] [Related]  

  • 39. How is immunosuppressive status affecting children and adults in SARS-CoV-2 infection? A systematic review.
    Minotti C; Tirelli F; Barbieri E; Giaquinto C; Donà D
    J Infect; 2020 Jul; 81(1):e61-e66. PubMed ID: 32335173
    [TBL] [Abstract][Full Text] [Related]  

  • 40. COVID-19 in persons with haematological cancers.
    He W; Chen L; Chen L; Yuan G; Fang Y; Chen W; Wu D; Liang B; Lu X; Ma Y; Li L; Wang H; Chen Z; Li Q; Gale RP
    Leukemia; 2020 Jun; 34(6):1637-1645. PubMed ID: 32332856
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.